MORGANTI, MARIA TERESA
MORGANTI, MARIA TERESA
Farmacologia preclinica e clinica 'M. Aiazzi Mancini' (attivo dal 01/08/1980 al 31/12/2012)
Identification of pharmacogenomic markers of 5-fluorouracil-based chemotherapy in colorectal cancer
2008 Napoli C, Nobili S, Morganti M, Landini I, Cianchi F, Valanzano R, Tonelli F, Mazzei T, Mini E
In vitro activity of folate antagonists against methotrexate-resistant CCRF-CEM human T-leukemia sublines and relationships with folate pathway gene expression profiles
2008 Landini I, Napoli C, Nobili S, Morganti M, Rigacci L, Bosi A, Mini E
Marked variation thymidylate synthase (TS) and folylpolyglutamate synthetase (FPGS) gene expression in human colorectal cancer
1998 Mini E, Biondi C, Morganti M, Napoli C, Mazzoni P, Cianchi F, Rossi S, Tonelli F, Cortesini C, Mazzei T
Mechanisms of methotrexate (MTX) resistance in human colon carcinoma cells DLD-1
2001 Caciagli B, Carotti S, Landini I, Morganti M, Nobili S, Coronnello M, Jansen G, Peters GJ, Toffoli G, Priest DG, Mini E
Thymidylate synthase and orotate phosphoribosyl-transferase gene expression and genotype as predictors for clinical outcome in colorectal cancer patients treated with 5-fluorouracil
2008 Vignoli M, Nobili S, Napoli C. Putignano AL, Morganti M, Papi L, Mini E, Genuardi M